BRIEF-Coherus Biosciences Says Capacity Constraints At Labeling & Packaging Facility To Cause Udenyca Supply Interruption

Reuters

14 Sep 2024

Sept 13 (Reuters) - Coherus BioSciences Inc :

* COHERUS BIOSCIENCES: A 3RD-PARTY CMO SAID CAPACITY CONSTRAINTS AT FINAL LABELING & PACKAGING FACILITY TO CAUSE TEMPORARY UDENYCA SUPPLY INTERRUPTION

* COHERUS BIOSCIENCES INC - PROJECTS CHANNEL SUPPLY UDENYCA TO BE SUBSTANTIALLY DEPLETED BY MID-OCTOBER AS INVENTORIES DRAW DOWN

* COHERUS BIOSCIENCES: EXPECTS UDENYCA MANUFACTURING TO RESUME IN MID-OCTOBER, WITH PRODUCT AVAILABILITY TO BEGIN TO RESUME BY EARLY NOVEMBER

* COHERUS BIOSCIENCES - TO WORK WITH WHOLESALERS & PRESCRIBERS TO MINIMIZE ANY DISRUPTION FROM TEMPORARY SUPPLY INTERRUPTION

* COHERUS BIOSCIENCES INC - COMPANY PROJECTS THAT THESE ACTIONS WILL COLLECTIVELY REDUCE PRODUCTION COST OF UDENYCA BY APPROXIMATELY ONE-THIRD FROM CURRENT LEVELS

* COHERUS BIOSCIENCES - ENGAGED ADDITIONAL FINAL PACKAGING & LABELING CMO, TO MANUFACTURE UDENYCA BY 2024 END

* COHERUS BIOSCIENCES- COMMERCIAL SUPPLY OF UDENYCA FROM NEW CMO TO START IN Q1 2025

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2467801310"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2467801310\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2467801310?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-14 06:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2467801310","market":"us","top_or_hot":-1,"title":"BRIEF-Coherus Biosciences Says Capacity Constraints At Labeling & Packaging Facility To Cause Udenyca Supply Interruption","media":"Reuters","content":"<html><body><p>Sept 13 (Reuters) - Coherus BioSciences Inc   :</p><p>   * COHERUS BIOSCIENCES: A 3RD-PARTY CMO SAID CAPACITY CONSTRAINTS AT FINAL LABELING & PACKAGING FACILITY TO CAUSE TEMPORARY UDENYCA SUPPLY INTERRUPTION</p><p>   * COHERUS BIOSCIENCES INC -  PROJECTS CHANNEL SUPPLY UDENYCA TO BE SUBSTANTIALLY DEPLETED BY MID-OCTOBER AS INVENTORIES DRAW DOWN</p><p>   * COHERUS BIOSCIENCES: EXPECTS UDENYCA MANUFACTURING TO RESUME IN MID-OCTOBER, WITH PRODUCT AVAILABILITY TO BEGIN TO RESUME BY EARLY NOVEMBER</p><p>   * COHERUS BIOSCIENCES - TO WORK WITH WHOLESALERS & PRESCRIBERS TO MINIMIZE ANY DISRUPTION FROM TEMPORARY SUPPLY INTERRUPTION</p><p>   * COHERUS BIOSCIENCES INC - COMPANY PROJECTS THAT THESE ACTIONS WILL COLLECTIVELY REDUCE PRODUCTION COST OF UDENYCA BY APPROXIMATELY ONE-THIRD FROM CURRENT LEVELS</p><p>   * COHERUS BIOSCIENCES - ENGAGED ADDITIONAL FINAL PACKAGING & LABELING CMO, TO MANUFACTURE UDENYCA BY 2024 END</p><p>   * COHERUS BIOSCIENCES- COMMERCIAL SUPPLY OF UDENYCA FROM NEW CMO TO START IN Q1 2025</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>BRIEF-Coherus Biosciences Says Capacity Constraints At Labeling & Packaging Facility To Cause Udenyca Supply Interruption</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Coherus Biosciences Says Capacity Constraints At Labeling & Packaging Facility To Cause Udenyca Supply Interruption\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2024-09-14 06:18</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Sept 13 (Reuters) - Coherus BioSciences Inc   :</p><p>   * COHERUS BIOSCIENCES: A 3RD-PARTY CMO SAID CAPACITY CONSTRAINTS AT FINAL LABELING & PACKAGING FACILITY TO CAUSE TEMPORARY UDENYCA SUPPLY INTERRUPTION</p><p>   * COHERUS BIOSCIENCES INC -  PROJECTS CHANNEL SUPPLY UDENYCA TO BE SUBSTANTIALLY DEPLETED BY MID-OCTOBER AS INVENTORIES DRAW DOWN</p><p>   * COHERUS BIOSCIENCES: EXPECTS UDENYCA MANUFACTURING TO RESUME IN MID-OCTOBER, WITH PRODUCT AVAILABILITY TO BEGIN TO RESUME BY EARLY NOVEMBER</p><p>   * COHERUS BIOSCIENCES - TO WORK WITH WHOLESALERS & PRESCRIBERS TO MINIMIZE ANY DISRUPTION FROM TEMPORARY SUPPLY INTERRUPTION</p><p>   * COHERUS BIOSCIENCES INC - COMPANY PROJECTS THAT THESE ACTIONS WILL COLLECTIVELY REDUCE PRODUCTION COST OF UDENYCA BY APPROXIMATELY ONE-THIRD FROM CURRENT LEVELS</p><p>   * COHERUS BIOSCIENCES - ENGAGED ADDITIONAL FINAL PACKAGING & LABELING CMO, TO MANUFACTURE UDENYCA BY 2024 END</p><p>   * COHERUS BIOSCIENCES- COMMERCIAL SUPPLY OF UDENYCA FROM NEW CMO TO START IN Q1 2025</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2467801310","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2467801310","pubTimestamp":1726265930,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Sept 13  - Coherus BioSciences Inc   :   * COHERUS BIOSCIENCES: A 3RD-PARTY CMO SAID CAPACITY CONSTRAINTS AT FINAL LABELING & PACKAGING FACILITY TO CAUSE TEMPORARY UDENYCA SUPPLY INTERRUPTION   * COHERUS BIOSCIENCES INC -  PROJECTS CHANNEL SUPPLY UDENYCA TO BE SUBSTANTIALLY DEPLETED BY MID-OCTOBER AS INVENTORIES DRAW DOWN   * COHERUS BIOSCIENCES: EXPECTS UDENYCA MANUFACTURING TO RESUME IN MID-OCTOBER, WITH PRODUCT AVAILABILITY TO BEGIN TO RESUME BY EARLY NOVEMBER   * COHERUS BIOSCIENCES - TO WORK WITH WHOLESALERS & PRESCRIBERS TO MINIMIZE ANY DISRUPTION FROM TEMPORARY SUPPLY INTERRUPTION   * COHERUS BIOSCIENCES INC - COMPANY PROJECTS THAT THESE ACTIONS WILL COLLECTIVELY REDUCE PRODUCTION COST OF UDENYCA BY APPROXIMATELY ONE-THIRD FROM CURRENT LEVELS   * COHERUS BIOSCIENCES - ENGAGED ADDITIONAL FINAL PACKAGING & LABELING CMO, TO MANUFACTURE UDENYCA BY 2024 END   * COHERUS BIOSCIENCES- COMMERCIAL SUPPLY OF UDENYCA FROM NEW CMO TO START IN Q1 2025Source text for Eikon:    Further company ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","CHRS":"Coherus Biosciences","BK4535":"淡马锡持仓"},"translate_title":"简介-Coherus Biosciences表示贴标和包装工厂的产能限制导致Udenyca供应中断","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CHRS":0.9},"content_text":"Sept 13 (Reuters) - Coherus BioSciences Inc   :   * COHERUS BIOSCIENCES: A 3RD-PARTY CMO SAID CAPACITY CONSTRAINTS AT FINAL LABELING & PACKAGING FACILITY TO CAUSE TEMPORARY UDENYCA SUPPLY INTERRUPTION   * COHERUS BIOSCIENCES INC -  PROJECTS CHANNEL SUPPLY UDENYCA TO BE SUBSTANTIALLY DEPLETED BY MID-OCTOBER AS INVENTORIES DRAW DOWN   * COHERUS BIOSCIENCES: EXPECTS UDENYCA MANUFACTURING TO RESUME IN MID-OCTOBER, WITH PRODUCT AVAILABILITY TO BEGIN TO RESUME BY EARLY NOVEMBER   * COHERUS BIOSCIENCES - TO WORK WITH WHOLESALERS & PRESCRIBERS TO MINIMIZE ANY DISRUPTION FROM TEMPORARY SUPPLY INTERRUPTION   * COHERUS BIOSCIENCES INC - COMPANY PROJECTS THAT THESE ACTIONS WILL COLLECTIVELY REDUCE PRODUCTION COST OF UDENYCA BY APPROXIMATELY ONE-THIRD FROM CURRENT LEVELS   * COHERUS BIOSCIENCES - ENGAGED ADDITIONAL FINAL PACKAGING & LABELING CMO, TO MANUFACTURE UDENYCA BY 2024 END   * COHERUS BIOSCIENCES- COMMERCIAL SUPPLY OF UDENYCA FROM NEW CMO TO START IN Q1 2025Source text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1}}}